1. Home
  2. CYTK vs SNAP Comparison

CYTK vs SNAP Comparison

Compare CYTK & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$69.27

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Logo Snap Inc.

SNAP

Snap Inc.

HOLD

Current Price

$5.34

Market Cap

10.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
SNAP
Founded
1997
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Programming Data Processing
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.4B
10.3B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
CYTK
SNAP
Price
$69.27
$5.34
Analyst Decision
Strong Buy
Hold
Analyst Count
19
26
Target Price
$89.26
$8.41
AVG Volume (30 Days)
1.7M
32.7M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.71
EPS
N/A
N/A
Revenue
$13,368,000.00
$824,949,000.00
Revenue This Year
$7.37
$15.55
Revenue Next Year
$310.19
$9.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
103.95
52 Week Low
$31.99
$3.81
52 Week High
$80.20
$10.41

Technical Indicators

Market Signals
Indicator
CYTK
SNAP
Relative Strength Index (RSI) 45.21 39.04
Support Level $59.07 $4.65
Resistance Level $70.69 $5.52
Average True Range (ATR) 2.87 0.26
MACD -1.15 -0.06
Stochastic Oscillator 25.26 12.97

Price Performance

Historical Comparison
CYTK
SNAP

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About SNAP Snap Inc.

Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.

Share on Social Networks: